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ABSTRACT
Neurons are a diverse cell type exhibiting hugely different morphologies and neurotransmitter specifications.
Their distinctive phenotypes are established during differentiation from pluripotent precursor cells. The
signalling pathways that specify the lineage down which neuronal precursor cells differentiate remain to be
fully elucidated. Among the many signals that impinge on the differentiation of neuronal cells, cytosolic
calcium (Ca2+) has an important role. However, little is known about the nature of the Ca2+ signals involved
in fate choice in neuronal precursor cells, or their sources. In this study, we show that activation of either
muscarinic or platelet-derived growth factor (PDGF) receptors induces a biphasic increase in cytosolic Ca2+
that consists of release from intracellular stores followed by sustained entry across the plasma membrane. For
both agonists, the prolonged Ca2+ entry occurred via a store-operated pathway that was pharmacologically
indistinguishable from Ca2+ entry initiated by thapsigargin. However, muscarinic receptor-activated Ca2+
entry was inhibited by siRNA-mediated knockdown of TRPC6, whereas Ca2+ entry evoked by PDGF was not.
These data provide evidence for agonist-specific activation of molecularly distinct store-operated Ca2+ entry
pathways, and raise the possibility of privileged communication between these Ca2+ entry pathways and
downstream processes.
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INTRODUCTION
The cells required for brain development
and growth are generated through the
proliferation and differentiation of a
populat ion of  neuronal  s tem cel ls
(Reynolds and Weiss, 1992). As well as
being present in the developing brain, stem
cells have recently been identified in
several regions of the adult brain (Alvarez-
Buylla and Temple, 1998; Cameron and
McKay, 1998; Gage, 1998). Such neuronal
stem cells may be responsible for the
replacement of dying or damaged neurons
(Armstrong and Svendsen, 2000; Gage,
1998; McKay, 2000; Reynolds and Weiss,
1992). These neuronal stem cells can be
isolated and maintained in culture, and
given the right cues they can differentiate
into all the major cell types of the brain:
astrocytes, oligodendrocytes and neurons
(Gage, 1998; McKay, 2000; Svendsen et
al., 1998). In addition, in vitro application
of mitogens, such as epidermal growth
factor, PDGF and fibroblast growth factor,
cause these stem cells to self-renew, to
form a three-dimensional structure called a
neurosphere from which neuronal cells can
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be obtained and studied (Caldwell et al.,
2001; Doetsch et al., 2002).
Stem cells and their more committed
daughter cells (neural precursor cells) have
been cited as a possible source of tissue to
replace dead, dying or damaged neurons in
patients suffering from particular
neurodegenerative disorders (Gage, 1998;
McKay, 2000). For example, embryonic
ventral mesencephalon cells have been
successfully transplanted into the striatum of
patients suffering from Parkinson’s disease,
producing a lasting symptomatic
improvement (Dunnett et al., 2001).
However, these primary cells are not readily
available, whereas human neurosphere-
derived cells (NDCs) can be expanded in
vitro after dissection (Svendsen et al., 2001;
Svendsen et al., 1998). NDCs therefore
potentially represent an alternative source of
neuronal cells without the ethical concerns
associated with embryonic stem cells.
Disappointingly, however, these cells have
yet to show the same migration,
differentiation and integration potential as
their totipotent embryonic counterparts
(Caldwell et al., 2001).
To provide insight into the mechanisms
that control NDC fate, research has focussed
on understanding the environmental factors
and signalling pathways that control their
proliferation and differentiation. It is apparent
that diffusible factors within the developing
brain create specific microenvironments that
through defined signalling pathways direct
stem cell fate choices (Spradling et al., 2001).
These include growth factors, neurotrophins,
cytokines, or more general neurotransmitters,
such as those that are released by astrocytes at
the site of brain injury (Ridet et al., 1997). It
is likely that identification of the
environmental cues and signalling pathways
that specify the lineage down which neuronal
precursor cells differentiate will have
considerable clinical benefit (Armstrong and
Svendsen, 2000).
Stimulation of neural stem cells with a
range of physiological agonists, including
neurotransmitters, such as acetylcholine, or
growth factors including PDGF, promotes
neural stem cell  proliferation and/or
differentiation (Erlandsson et al., 2001; Ma
et al., 2000). Common to all of these
agonists is the engagement of the
phospholipase C (PLC) signalling cascade
(Clapham, 1995). Upon activation, PLC
cleaves phosphatidylinositol 4,5-
bisphosphate into diacylglycerol (DAG)
and inositol 1,4,5-trisphosphate (InsP3).
DAG remains in the plane of the
membrane, whereas InsP3 is water-soluble
and diffuses through the cytosol to find its
cognate receptor on the ER and stimulates
Ca2+ release (Berridge et al., 2003). To
replenish the depleted ER Ca2+ store, a
plasma membrane Ca2+ influx pathway
known as store-operated Ca2+ entry (SOCE)
is activated (Parekh and Putney, 2005;
Putney, 1986). In addition to activating
SOCE, other downstream products of PLC
activation, including DAG and arachidonic
acid, have been demonstrated to stimulate
non-store operated Ca2+ entry (Chyb et al.,
1999; Moneer and Taylor, 2002; Peppiatt et
al., 2004; Shuttleworth and Thompson,
1999). Ca2+ influx arising from these entry
pathways serves to prolong the duration of
the agonist-induced Ca2+ signals with long-
term consequences for cell function (Parekh
and Putney, 2005).
It is well established that Ca2+ signals are
central to neuronal physiology, controlling
development, migration, synaptic
transmission and memory consolidation
(Berridge, 1998; Spitzer, 2002). Through
regulation of the amplitude, frequency and
location of Ca2+ signals, extracellular stimuli
can specifically regulate diverse cellular
functions (Berridge, 1997). In particular,
hormones that signal through G-protein
coupled receptors are known to evoke
responses in fully differentiated neurons, and
control many aspects of brain function. For
example, the stimulation of muscarinic
acetylcholine receptors has been linked to
the modulation of synaptic plasticity
(Yamamoto et al., 2002), in addition to the
regulation of cholinergic and dopaminergic
neurotransmission (Delmas et al., 2002;
Lezcano and Bergson, 2002) and also the
regulation of gene expression (Caulfield,
1993; Ma et al., 2000; Simpson et al., 1994;
Zhao et al., 2003). Moreover, muscarinic
receptors expressed by neural precursors
transduce a growth-regulatory signal during
neurogenesis via signalling pathways that
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are known to evoke Ca2+ changes (Ma et al.,
2000). Based on these observations, we set
out to characterise the profile of the cellular
Ca2+ signals generated following cellular
stimulation by muscarinic receptor activation
in NDCs, and compared them to the Ca2+
increases caused by the established mitogen
PDGF.
METHODS
Neurosphere Culture
Human neural precursors (Clonetics¨,
Cambrex, East Rutherford, NJ) were grown
as neurospheres in Dulbecco’s Modified
Eagle’s Medium (DMEM; Sigma-Aldrich,
Poole, UK) /F12 (Invitrogen Life
Technologies, Paisley, UK) 3:1; N2, 1%
(Invitrogen Life Technologies); EGF, 20
ng/ml (Peprotech, London, UK) and LIF, 10
ng/ml (Chemicon, Hampshire, UK), as
previously described (Richards et al., 2004;
Richards et al., 2006). Neurospheres were
passaged every two weeks by chopping into
250 μm cubes using a tissue chopper
(Mickle Laboratory Engineering, Guildford,
UK). Cells were prepared for plating 7-12
days post-chopping following dissociation
with Accutase™ (1:5 HBSS, Innovative
Cell Technologies, San Diego, CA).
Briefly, neurospheres were washed three
times in phosphate-buffered saline (PBS,
Sigma-Aldrich), followed by the addition of
3 ml Accutase in HBSS (Invitrogen Life
Technologies) and left on a shaker for 30
minutes at 37ºC. After addition of PBS,
cells were dissociated by trituration with a
10 ml pipette. Cells were harvested by
centrifugation at 150g for 5 minutes, and
resuspended in standard plating medium
(DMEM/F12, 3:1; transferrin, 50 μg/ml
Merck Biosciences); insulin, 5 μg/ml;
progesterone, 20 nM; putrescine, 100 μM;
T3, 30 nM; selenium, 30 nM (all from
Sigma-Aldrich) with further trituration. For
microplate-based experiments, cells were
plated at 21,000 cells per well in 96-well
black-sided microtitre poly-D-lysine coated
plates (Biocoat™, BD Biosciences, Oxford,
UK) that had also been coated with laminin
(1 μg/ml (Sigma).
Cell-based Microplate Ca2+ Imaging
Cells were washed with Krebs/Hanks
Buffer (KHB) three times and incubated
with 5 μM Fluo-3-AM/0.004% pluronic
acid (Molecular Probes) for 1 hour at room
temperature. Following incubation, cells
were washed 3 times in KHB, and
transferred to a BD™ Pathway HT (BD
Biosciences) plate imager for compound
addition and image collection (Chan et al.,
2005). Data was analysed using an in-house
custom data analysis package to express
data as change in fluorescence over basal or
ΔF/F0.
ImmunoBlotting
NDCs were washed and scraped into ice-
cold PBS. Cell suspensions were
centrifuged at 1,000 rpm for 5 mins. Cells
were lysed by incubation for 1 hr on ice in
buffer containing: 10 mM Tris-HCl (pH
7.6), 140 mM NaCl, 1% Triton X-100, 5
mM NaF, 1 mM NaPPi, 0.02 mM leupeptin,
0.2 mM 4-(2-Aminoethyl)benzenesulfonyl
fluoride (AEBSF), as described previously
(Kasri et al., 2004). Proteins were resolved
by SDS-PAGE (10%) and electroblotted
onto 0.2 μm nitrocellulose membranes. The
membranes were incubated in blocking
buffer (Tris-buffered saline (TBS)
containing 0.1% Tween-20 (v/v) and 5%
skimmed milk (w/v)) for 1 hour at room
temperature, followed by overnight
incubation at 4°C in the same buffer
containing mouse anti-hTRPC6 (1:500;
Alomone) or anti-beta actin (1:10,000;
Sigma). Immunoreactive proteins were
detected using horse radish peroxidase-
(HRP-) conjugated anti-mouse IgG
(1:10,000, Jackson Immunoresearch) and
visualised with a chemiluminescent
substrate for HRP (ECL, Pierce Chemicals).
siRNA Transfection of NDCs
Reduction in hTRPC6 expression was
achieved by RNA interference (siRNA,
Elbashir et al., 2001a; Elbashir et al., 2001b).
SmartPool siRNAs consisting of four
different siRNA oligonucleotides targeted
against hTRPC6 were obtained from
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Dharmacon. Efficient silencing was assessed
by immunoblotting and immunofluorescence,
using a primary antibody directed against
hTRPC6 (Alamone). 0.1 μg siRNA duplex
was transfected using JetSI (QBiogene) per
well of a 96 well plate for imaging and
immunofluorescence according to
manufacturers instructions. 1 μg siRNA was
used per well of a 6 well plate for Western
blotting whit inmunoblotting.
Statistics
Statistical analysis of data was performed
using Student’s t-test in the case of two
samples or One-Way ANOVA using
Tukey’s Multiple Comparison test for three
or more samples. All experiments represent
an average of 3 or more experiments, each
using multiple wells of a 96 well plate,
unless otherwise specified. In all
experiments involving the ArrayScanII,
multiple fields were recorded within each
well this last sentencer.  Statistical
significance is denoted by: **p<0.01,
***p<0.001.
RESULTS
PDGF and MCH evoked biphasic Ca2+
responses
To explore the notion of Ca2+ as a signal
downstream of G-protein-coupled receptors
and growth factor receptors in NDCs, we
compared the kinetics and profiles of the
Ca2+ responses induced by a range of
concentrations of MCH and PDGF (Fig. 1).
Representative traces showing the response
of the cells to 0.3, 3 and 30 ng/ml PDGF
and 0.1, 10 and 100 μM MCH are shown in
figure 1A. It is evident that both agonists
evoked increases in cytosolic Ca2+ that
comprised of a rapid rise, which typically
reached a distinct peak, followed by a
prolonged elevation in intracellular Ca2+
that persisted for the duration of
stimulation. Extended dose response curves
indicated that application of MCH or PDGF
caused concentration-dependent effects.
The peak amplitude (data not shown) and
percentage of responding cells (Fig. 1B)
increased in direct proportion to the
concentration of agonist applied. Maximal
concentrations of either MCH or PDGF
evoked responses in almost all the cells
imaged. The latency (time from addition of
an agonist to the peak of the Ca2+ signal)
declined as the agonist concentration was
increased (Fig. 1C). It was evident that the
latency was significantly longer over the
full dose-response relationship for PDGF in
comparison to MCH (Fig. 1C).
To determine the contributions of Ca2+
release and Ca2+ entry to the responses
induced by PDGF and MCH, we examined
the effects of the agonists in the presence or
absence of extracellular Ca2+ (Fig. 2;
concentrations of MCH and PDGF giving
similar peak Ca2+ signals were used). The
initial responses evoked by either agonist
were not significantly affected by
extracellular Ca2+ (see Ca2+ traces in Fig.
2A and 2C and summarised data the
histograms in Fig. 2Bi and Di). However,
the extended elevation in cytosolic Ca2+,
which occurred when either agonist was
applied in the presence of extracellular
Ca2+, was abrogated in Ca2+-free conditions
(see Ca2+ traces in Fig. 2A and 2C and
summarised data the histograms in Fig. 2Bii
and Dii). In the absence of extracellular
Ca2+ the cytosolic elevation generally
returned to baseline levels within 150 - 200
seconds after initial stimulation (n = 3,
p<0.001, figs 2Aii and Cii). These data
indicate that the intracellular Ca2+ response
to PDGF and MCH consisted of an initial
spike, which represented Ca2+ release from
intracellular stores and a sustained
elevation that depended on extracellular
Ca2+. In many cells, the recovery of Ca2+
following stimulation in Ca2+-free media
did not follow a simple exponential decline.
Rather, there were frequently one or two
oscillations of the cytosolic Ca2+
concentration on the declining phase of the
response.
Methacholine and PDGF activate a store-
operated Ca2+ entry pathway in NDCs
Having established that Ca2+ influx
contributed to the cytosolic Ca2+ transient
induced by PDGF and MCH, we next
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Figure 1: Characterisation of MCH- and PDGF-induced Ca2+ signals in NDCs. A,
Representative traces of the Ca2+ responses induced by the indicated agonist concentrations. B,
concentration-dependent effect of MCH and PDGF on the proportion of responsive cells. A change
in fluorescence signal (ΔF/F0) >1.1 was classified as a response. C, averaged data (Mean ± SEM, n
> 1000 cells for each condition) indicating the latency (time from agonist addition to the peak of
the response) for MCH- and PDGF-stimulated Ca2+ signals.
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Figure 2: PDGF and MCH induce Ca2+ release from intracellular stores and Ca2+ influx
across the plasma membrane. A and C, representative responses from single NDCs stimulated
with the indicated agonist either in (i) Ca2+-containing or (ii) Ca2+-free medium. B and D, averaged
data (Mean ± SEM, n > 1000 cells for each condition) summarising: (i) the peak Ca2+ release
amplitude (measured 50 – 100 s after agonist addition), and (ii) amplitude of the Ca2+ (entry) signal
measured at 300 s post addition of the agonist. *** indicates significance (p < 0.001), and ‘ns’
indicates lack of significant difference.
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investigated the pharmacological profile of
the pathway responsible for the entry of
Ca2+. In particular, we employed the
established Ca2+ entry antagonists SKF-
96365 and gadolinium (Gd3+). The former
compound has been used in many studies to
probe SOCE (Baba et al., 2003; Flemming
et al., 2003; Vostal and Shafer, 1996).
Differential sensitivity to high (100 μM) or
low (1 μM) concentration of lanthanides,
such as Gd3+, has been used previously to
investigate whether Ca2+ entry is arising
through a store-operated or non store-
operated Ca2+ entry pathway (Broad et al.,
1999).
Experiments were performed to test the
relative sensitivities of PDGF and MCH-
induced Ca2+ entry to 10 μM SKF-96365
and 1 μM Gd3+. As a positive control, the
effect of these inhibitors upon Ca2+ entry
induced by thapsigargin was also tested.
Thapsigargin is an irreversible inhibitor of
the sarcoplasmic endoplasmic reticulum
ATPase (SERCA), and it depletes the ER
Ca2+ store resulting in robust and specific
activation of SOCE (Holmes et al., 2007).
To uncover the effect of SKF-96365 and
Gd3+ on Ca2+ entry induced by MCH or
PDGF, a protocol was used that involved
store depletion by agonist application in the
absence of extracellular Ca2+, followed by
activation of Ca2+ entry due to re-addition of
Ca2+ to the extracellular medium. As shown
in figures 3A and B, application of either
MCH or PDGF to the cells in Ca2+-free
medium evoked an initial rise in intracellular
Ca2+, which was due to release from
intracellular stores. After this increase in
intracellular Ca2+ had returned to baseline
levels, Ca2+ was added to the extracellular
medium resulting in an elevation in
intracellular Ca2+ due to influx across the
plasma membrane. Application of 1 μM
Gd3+ completely abrogated Ca2+ entry
induced by both MCH and PDGF (Figs. 3A
and B). This was manifest as a decrease in
both the peak Ca2+ signal and integrated
Ca2+ transient following Ca2+ re-addition
(Figs. 3A and B). No effect of Gd3+ was seen
on the MCH- or PDGF-induced Ca2+ release.
Gd3+ exhibited a similarly complete degree
of inhibition upon Ca2+ influx following
store depletion with thapsigargin (Fig. 3C).
SKF-96365 also significantly reduced the
Ca2+ entry signal induced by both MCH and
PDGF, without affecting Ca2+ release (Figs.
3A and B). The degree of inhibition of
PDGF- and MCH-induced Ca2+ entry by
SKF-96365 was not as great as that observed
for Gd3+ (Fig. 3A and B). The reduced
efficacy of SKF-96365, compared to Gd3+,
in inhibiting Ca2+ influx induced by MCH
and PDGF was also mirrored by its lower
potency in inhibiting thapsigargin-induced
Ca2+ entry (Fig. 3C). These data indicate that
Ca2+ signals induced by MCH, PDGF- and
thapsigargin were similarly affected by Gd3+
and SKF-96365.
We also tested the possibility that MCH
or PDGF could activate alternative, non-
SOCE, Ca2+ entry pathways. This was
examined by applying MCH or PDGF to
cells during an on-going SOCE signal that
had been activated by thapsigargin (Fig. 4).
As a positive control, we also utilised
calmidazolium (CMZ), which we have
previously demonstrated to activate a non-
SOCE pathway (Holmes et al.,  2007;
Peppiatt et al., 2004). Cells were treated
with thapsigargin for 20 minutes to
completely discharge the ER and activate
SOCE. Subsequently, MCH, PDGF or
calmidazolium were added. Of these agents,
only calmidazolium triggered an additional
Ca2+ influx. The similarity of the
pharmacological profiles of both MCH-,
PDGF- or thapsigargin-induced Ca2+ influx,
and the inability of MCH or PDGF to
induce further Ca2+ entry after thapsigargin-
mediated SOCE activation, suggests that a
common Ca2+ entry mechanism is activated
by all three agents.
MCH-activated SOCE is dependent upon
TRPC6 expression
TRP channels have been suggested to
underlie store-operated Ca2+ entry in a
number of cell types, and play important
roles in neuronal physiology. Microarray
analysis of our NDCs revealed that mRNAs
for TRPC5 and TRPC6 were abundant (data
not shown). We considered the possibility
that TRPC5 might underlie the Ca2+ entry
signals that we see. However, TRPC5 has
been shown to negatively regulate neuronal
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Figure 3: PDGF- and MCH-stimulated Ca2+ entry is pharmacologically similar to
thapsigargin-activated SOCE. Ca2+ influx in response to cellular stimulation with MCH, PDGF
and Thapsigargin was imaged in NDCs. Following depletion of the intracellular Ca2+ store,
extracellular Ca2+ (1.3 mM) was added back to the cells in the presence or absence of Gd3+ (1 μM)
or SKF-96365 (10 μM). Ai – Ci, representative traces showing responses to MCH, PDGF and
thapsigargin, in the presence or absence of the Ca2+ entry inhibitors. Aii – Cii, averaged data (Mean
± SEM, n > 1000 cells for each condition) indicating the integrated Ca2+ signal (i.e. area under the
Ca2+ trace) measured for 10 minutes following readdition of extracellular Ca2+. * indicates
statistically significance (p < 0.05).
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outgrowth (Greka et al., 2003), but Ca2+
entry potentiates neurite outgrowth in our
NDCs (unpublished observations).
Furthermore, TRPC5 activity is potentiated
by lanthanides (Clapham et al., 2001),
whereas we observed an inhibition of Ca2+
entry by Gd3+. For these reasons, TRPC5
was not considered further during this study.
TRPC6 appeared an attractive candidate as it
has previously been implicated in mediating
SOCE in other cell types (Yuan et al., 2003).
The role of TRPC6 in PDGF-,
Thapsigargin- and MCH-induced Ca2+ entry
into NDCs was examined by exploiting
specifically-targeted siRNAs to reduce
protein expression. NDCs were transfected
with pooled siRNAs designed against four
regions of TRPC6 mRNA for 24 hours, after
which TRPC6 expression was investigated
by immunoblotting (figure 5A). Parallel
experiments using a fluorescent, Cy3-
conjugated siRNA indicated that greater than
90% transfection efficiency was achieved
using the transfection protocol (Fig. 5B).
Endogenous TRPC6 in mouse brain lysates,
and in lysates prepared from the untreated
control NDCs was detected as two bands.
These two bands are proposed to represent
endogenous TRPC6 (~106 kDa) and a splice
variant (~50 kDa). Following 24 hours
TRPC6 siRNA transfection, TRPC6 protein
levels were substantially reduced (the 106
kD band by 66%, and the 50 kD band by
50%).
For Ca2+ imaging experiments, NDCs
were transfected with TRPC6 siRNA 24
hours  prior to experimentation. Cy3-
conjugated, luciferase-directed siRNAs
were used for control. TRPC6 siRNA and
Cy3-conjugated siRNA transfected cells
were stimulated with MCH (10 μM),
thapsigargin (2 μM), or PDGF (30 ng/ml)
in the absence of extracellular Ca2+ to
deplete the intracellular Ca2+ store. SOCE
was subsequently initiated by addition of
Ca2+ to the extracellular buffer (Fig. 5Ci-
Ei). TRPC6 reduction had no effect upon
the amplitude of the initial Ca2+ transients
arising through release from intracellular
Ca2+ stores. However, TRPC6 siRNA
transfection had different effects upon
SOCE induced by PDGF, MCH or
thapsigargin. Specifically, MCH-induced
Ca2+ entry was significantly reduced in
cells transfected with TRPC6 siRNA when
compared with control-transfected cells
(Fig. 5Cii). Whereas, TRPC6 reduction did
not affect thapsigargin- or PDGF-induced
Ca2+ influx (Figure 5Dii and Eii).
DISCUSSION
It has been demonstrated that Ca2+ signals
play a key role in neuronal development
controlling differentiation, neurite
Figure 4: The Ca2+ influx stimulated by
PDGF or MECH is not additive with
thapsigargin-activated SOCE. A ,
representative traces showing the lack of effect
of PDGF (30 ng/ml) or MCH (10 μM) during an
on-going thapsigargin-evoked SOCE signal.
Calmidazolium (10 μM) was used as a positive
control, and did induce additional Ca2+ influx.
B, averaged data (Mean ± SEM, n > 100 cells
for each condition) indicating the net effect of
calmodazolium, PDGF or MCH to the
thapsigargin-evoked SOCE response.
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Figure 5: TRPC6 is a component of MCH-induced Ca2+ entry. A, upper panels, immunoblots
showing the abundance of the 105 kDA and 50 kDa splice variants of TRPC6 in mouse brain lysate,
and in lysates prepared from NDCs 24 h post-transfection with control Cy3-conjugated luciferase
siRNA or TRPC6 siRNA. Lower panel, immunoblot showing the abundance of β-actin (used as a
loading control) in the lysates described above. B, Representative overlay image of cells loaled
with calcein (marker of cell viability, green) and Cy3-tagged luciferase siRNA (control siRNA,
red). Ci - Ei, typical traces showing MCH-, PDGF- and thapsigargin-induced Ca2+ influx in NDCs
24 hours post transfection with TRPC6 siRNA or control Cy3-conjugated luciferase siRNA. Data is
shown as mean ± SEM (n > 500 cells). Cii - Eii, averaged data (Mean ± SEM, n > 1000 cells for
each condition) indicating the integrated Ca2+ signal (i.e. area under the Ca2+ trace) measured for 8
minutes following readdition of extracellular Ca2+. * indicates statistically significance (p < 0.01).
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outgrowth and pathfinding (Bezzerides et
al., 2004; Shim et al., 2005). Indeed, we
have previously shown that PDGF induces
neurite outgrowth in NDCs in a Ca2+-
dependent manner (Richards et al., 2006).
Stimulation of muscarinic receptors, on the
other hand, promotes NDC proliferation
without neurite outgrowth (unpublished
observations). An aim of this study was to
examine whether the differing biological
outcomes (i.e. neurite outgrowth versus
proliferation) caused by PDGF and
muscarinic receptor stimulation was due to
alternative patterns of Ca2+ signalling.
Ca2+ transients elicited by both agonists
were comprised of Ca2+ release from finite
intracellular stores, followed by a
prolonged elevated level of intracellular
Ca2+, which was due to Ca2+ flux across the
plasma membrane (Figs. 1 and 2). The
pattern of Ca2+ signals evoked by PDGF
and MCH in NDCs is typical of the
response of many different cell types to
InsP3-generating agonists (Bootman et al.,
1992; Trebak et al., 2002b). Ca2+ entry
induced by both PDGF and MCH was
pharmacologically similar to the SOCE
pathway initiated by ER Ca2+ store
depletion with thapsigargin (Fig. 3).
Although the amplitudes of the Ca2+
transients induced by either MCH or PDGF
were similar at maximal concentrations, the
time taken to reach the peak of the Ca2+
transient was typically greater for PDGF
than MCH (Fig. 1). This increased latency
became more pronounced with decreasing
agonist concentrations. These differences
can in part be ascribed to the different
kinetics of InsP3 generation downstream of
PDGFR and mAChR activation.
Stimulation by PDGF results in
dimerisation of plasma membrane-localised
receptors and phosphorylation of serine and
tyrosine residues, which leads to
downstream activation of PLCγ (Clapham,
1995). A recent study presented evidence
for a lipase-independent role for PLCγ in
the activation of Ca2+ entry (Patterson et
al., 2002), suggesting that rather than Ca2+
release from intracellular stores driving
Ca2+ entry, PDGFRs could couple directly
to Ca2+ entry channels with which they co-
localise in signalling microdomains
(Ambudkar et al., 2004). Although our data
cannot rule out such a mechanism for
PDGF-evoked Ca2+ entry, we did not
observe any additional Ca2+ influx when
PDGF was applied to NDCs with an on-
going SOCE response (Fig. 4). This would
suggest that any store-independent Ca2+
entry activated by PDGF is less profound
than SOCE.
In this study, PDGF and MCH were both
found to activate SOCE. This conclusion
was based upon the findings that they
released Ca2+ from intracellular stores, and
that the Ca2+ entry stimulated by both
agonists was sensitive to Gd3+ and SKF-
96365, which are known inhibitors of
SOCE. The degree of inhibition of MCH-
and PDGF-evoked Ca2+ influx by Gd3+ and
SKF-96365 was similar to the reduction of
SOCE when it was induced by thapsigargin.
The incomplete inhibition of Ca2+ entry by
SKF-96365 is typical of its effects seen in
other systems (Merritt  et  al. ,  1990;
Vassilopoulos et al., 2007). Although the
Ca2+ entry pathways activated by PDGF,
MCH and thapsigargin were
pharmacologically indistinguishable from
each other, we detected a differential
sensitivity to reduction of TRPC6 (Fig. 5).
siRNA-mediated knockdown of TRPC6
resulted in a profound decrease in the
magnitude of MCH-induced Ca2+ entry. No
effect on Ca2+ entry induced by PDGF or
thapsigargin was however seen. Although
TRPC6 was initially characterised as a
DAG-activated cation channel (Hofmann et
al., 1999), other reports suggest that it may
mediate SOCE (Singh et al., 2007; Yu et
al., 2003). In certain cellular contexts,
TRPC3 and 7, other members of the TRPC
subclass to which TRPC6 belongs, have
also been reported to form store-operated
channels. For example, when expressed at
low levels, TRPC3 and 7, form channels
that are store-operated, whereas when
highly overexpressed they form channels
that are non-store operated (Lievremont et
al., 2004; Trebak et al., 2002a).
Given that Ca2+ is a profound regulator
of neuronal behaviour, the channels that
underlie its movement represent attractive
targets for therapeutic intervention. We
have previously found that stimulation of
CUDDON ET AL. Biol Res 41, 2008, 183-195194
NDCs with PDGF or MCH results in
different biological outcomes. In our hands,
the former agonist promotes NDC
proliferation neurite outgrowth, whilst the
latter stimulates proliferation but not
neurite extension. It is likely that Ca2+ is a
key signal in both of these activities. At a
gross level, the Ca2+ signals evoked by
MCH and PDGF are very similar. However,
probing the molecular nature of the
pathways responsible for Ca2+ influx
reveals that MCH and PDGF do not employ
the same channels. It is therefore possible
that subtle differences in the spatial
distribution of the Ca2+ channels recruited
by MCH or PDGF, along with the
engagement of other signalling elements,
allow these two agonists to produce
distinctive biological effects.
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